【7897】ホクシン

中質繊維版。大株主に兼松。

類似企業：

【業界1位】ヤマハ

【売上同水準】アルメディオ ドリームベット

東証スタンダード

その他製品製他

＞

その他製品製他

売上高

営業利益

経常利益

当期利益

業績予想修正

対前回修正率

当初予想比較

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.03	2025/02/28	修正予	10,200	↓	-10.5%	-10.5%	-70	↓	-163.6%	-163.6%	-60	↓	-160.0%	-160.0%	10	↓	-85.7%	-85.7%
2025.03	2025/01/31	Q3予	11,400	→	0.0%	0.0%	110	→	0.0%	0.0%	100	→	0.0%	0.0%	70	→	0.0%	0.0%
2025.03	2024/10/31	Q2予	11,400	→	0.0%	0.0%	110	→	0.0%	0.0%	100	→	0.0%	0.0%	70	→	0.0%	0.0%
2025.03	2024/07/26	Q1予	11,400	→	0.0%	0.0%	110	→	0.0%	0.0%	100	→	0.0%	0.0%	70	→	0.0%	0.0%
2025.03	2024/04/26	当初予	11,400	-	-	-	110	-	-	-	100	-	-	-	70	-	-	-
2024.03	2024/04/26	実	10,979	↓	-0.2%	-15.5%	126	↑	+14.5%	-40.0%	190	↑	+11.8%	-9.5%	158	↑	+12.9%	+12.9%
2024.03	2024/01/26	Q3予	11,000	→	0.0%	-15.4%	110	↑	+57.1%	-47.6%	170	↑	+70.0%	-19.0%	140	↑	+27.3%	0.0%
2024.03	2023/10/27	Q2予	11,000	→	0.0%	-15.4%	70	→	0.0%	-66.7%	100	→	0.0%	-52.4%	110	→	0.0%	-21.4%
2024.03	2023/09/29	修正予	11,000	↓	-15.4%	-15.4%	70	↓	-66.7%	-66.7%	100	↓	-52.4%	-52.4%	110	↓	-21.4%	-21.4%
2024.03	2023/07/31	Q1予	13,000	→	0.0%	0.0%	210	→	0.0%	0.0%	210	→	0.0%	0.0%	140	→	0.0%	0.0%
2024.03	2023/04/28	当初予	13,000	-	-	-	210	-	-	-	210	-	-	-	140	-	-	-
2023.03	2023/04/28	実	12,887	↑	+0.7%	-0.9%	489	↓	-2.2%	+63.0%	489	↓	-0.2%	+81.1%	332	↓	-2.4%	+95.3%
2023.03	2023/03/24	修正予	12,800	↓	-6.6%	-1.5%	500	↓	-12.3%	+66.7%	490	↓	-12.5%	+81.5%	340	↓	-12.8%	+100.0%
2023.03	2023/01/27	Q3予	13,700	→	0.0%	+5.4%	570	→	0.0%	+90.0%	560	→	0.0%	+107.4%	390	→	0.0%	+129.4%
2023.03	2022/10/28	Q2予	13,700	↑	+1.5%	+5.4%	570	↑	+11.8%	+90.0%	560	↑	+14.3%	+107.4%	390	↑	+14.7%	+129.4%
2023.03	2022/07/29	Q1予	13,500	↑	+3.8%	+3.8%	510	↑	+70.0%	+70.0%	490	↑	+81.5%	+81.5%	340	↑	+100.0%	+100.0%
2023.03	2022/05/10	当初予	13,000	-	-	-	300	-	-	-	270	-	-	-	170	-	-	-
2022.03	2022/05/10	実	10,776	↑	+3.6%	+10.0%	436	↑	+45.3%	+263.3%	447	↑	+49.0%	+794.0%	377	↑	+25.7%	+1156.7%
2022.03	2022/01/28	修正予	-	-	-	-	-	-	-	-	-	-	-	-	300	↑	+50.0%	+900.0%
2022.03	2021/10/29	Q2予	10,400	→	0.0%	+6.1%	300	→	0.0%	+150.0%	300	→	0.0%	+500.0%	200	→	0.0%	+566.7%
2022.03	2021/09/30	修正予	10,400	↑	+6.1%	+6.1%	300	↑	+150.0%	+150.0%	300	↑	+500.0%	+500.0%	200	↑	+566.7%	+566.7%
2022.03	2021/07/30	Q1予	9,800	→	0.0%	0.0%	120	→	0.0%	0.0%	50	→	0.0%	0.0%	30	→	0.0%	0.0%
2022.03	2021/05/10	当初予	9,800	-	-	-	120	-	-	-	50	-	-	-	30	-	-	-
2021.03	2021/05/10	実	9,106	→	0.0%	+4.7%	129	→	0.0%	+422.5%	228	↑	+1.8%	+1040.0%	173	→	0.0%	+1630.0%
2021.03	2021/04/28	修正予	9,106	↑	+1.2%	+4.7%	129	↑	+43.3%	+422.5%	224	↑	+24.4%	+1020.0%	173	↑	+44.2%	+1630.0%
2021.03	2021/03/26	修正予	9,000	↑	+3.4%	+3.4%	90	↑	+325.0%	+325.0%	180	↑	+800.0%	+800.0%	120	↑	+1100.0%	+1100.0%
2021.03	2021/01/28	Q3予	8,700	→	0.0%	0.0%	-40	→	0.0%	0.0%	20	→	0.0%	0.0%	10	→	0.0%	0.0%
2021.03	2020/10/30	当初予	8,700	-	-	-	-40	-	-	-	20	-	-	-	10	-	-	-
2020.03	2020/04/30	実	10,539	↓	-2.4%	-8.4%	222	↑	+0.9%	+0.9%	247	↑	+7.4%	+7.4%	154	↑	+18.5%	+18.5%
2020.03	2020/01/31	Q3予	10,800	→	0.0%	-6.1%	220	→	0.0%	0.0%	230	→	0.0%	0.0%	130	→	0.0%	0.0%
2020.03	2019/10/25	Q2予	10,800	→	0.0%	-6.1%	220	→	0.0%	0.0%	230	→	0.0%	0.0%	130	→	0.0%	0.0%
2020.03	2019/09/27	修正予	10,800	↓	-6.1%	-6.1%	220	→	0.0%	0.0%	230	→	0.0%	0.0%	130	→	0.0%	0.0%
2020.03	2019/07/26	Q1予	11,500	→	0.0%	0.0%	220	→	0.0%	0.0%	230	→	0.0%	0.0%	130	→	0.0%	0.0%
2020.03	2019/04/26	当初予	11,500	-	-	-	220	-	-	-	230	-	-	-	130	-	-	-
2019.03	2019/04/26	実	11,366	↑	+2.4%	-2.9%	319	↑	+6.3%	-39.8%	339	↑	+5.9%	-37.2%	245	↑	+16.7%	-21.0%
2019.03	2019/01/25	Q3予	11,100	→	0.0%	-5.1%	300	→	0.0%	-43.4%	320	→	0.0%	-40.7%	210	→	0.0%	-32.3%
2019.03	2018/10/26	Q2予	11,100	↓	-5.1%	-5.1%	300	↓	-43.4%	-43.4%	320	↓	-40.7%	-40.7%	210	↓	-32.3%	-32.3%
2019.03	2018/07/27	Q1予	11,700	→	0.0%	0.0%	530	-	-	-	540	→	0.0%	0.0%	310	→	0.0%	0.0%
2019.03	2018/04/27	当初予	11,700	-	-	-	-	-	-	-	540	-	-	-	310	-	-	-
2018.03	2018/04/27	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.03	2018/01/26	Q3予	11,000	→	0.0%	0.0%	580	→	0.0%	+11.5%	590	→	0.0%	+13.5%	395	→	0.0%	+16.2%
2018.03	2017/10/27	Q2予	11,000	→	0.0%	0.0%	580	→	0.0%	+11.5%	590	→	0.0%	+13.5%	395	→	0.0%	+16.2%
2018.03	2017/09/29	修正予	11,000	→	0.0%	0.0%	580	↑	+11.5%	+11.5%	590	↑	+13.5%	+13.5%	395	↑	+16.2%	+16.2%
2018.03	2017/07/28	Q1予	11,000	→	0.0%	0.0%	520	→	0.0%	0.0%	520	→	0.0%	0.0%	340	→	0.0%	0.0%
2018.03	2017/04/28	当初予	11,000	-	-	-	520	-	-	-	520	-	-	-	340	-	-	-
2017.03	2017/04/28	実	11,497	↑	+0.4%	+1.7%	800	→	0.0%	+77.8%	792	↑	+0.3%	+84.2%	772	↑	+5.8%	+111.5%
2017.03	2017/01/27	Q3予	11,450	→	0.0%	+1.3%	800	↑	+23.1%	+77.8%	790	↑	+25.4%	+83.7%	730	↑	+22.3%	+100.0%
2017.03	2016/10/28	Q2予	11,450	→	0.0%	+1.3%	650	→	0.0%	+44.4%	630	→	0.0%	+46.5%	597	↑	+12.6%	+63.6%
2017.03	2016/09/30	修正予	11,450	↑	+1.3%	+1.3%	650	↑	+44.4%	+44.4%	630	↑	+46.5%	+46.5%	530	↑	+45.2%	+45.2%
2017.03	2016/07/29	Q1予	11,300	→	0.0%	0.0%	450	→	0.0%	0.0%	430	→	0.0%	0.0%	365	→	0.0%	0.0%
2017.03	2016/04/28	当初予	11,300	-	-	-	450	-	-	-	430	-	-	-	365	-	-	-
2016.03	2016/04/28	実	11,156	↑	+1.9%	+11.6%	330	↓	-4.3%	+65.0%	335	↓	-1.5%	+109.4%	362	↑	+13.1%	+178.5%
2016.03	2016/01/29	Q3予	10,950	→	0.0%	+9.5%	345	→	0.0%	+72.5%	340	→	0.0%	+112.5%	320	→	0.0%	+146.2%
2016.03	2016/01/21	修正予	10,950	↑	+9.5%	+9.5%	345	↑	+72.5%	+72.5%	340	↑	+112.5%	+112.5%	320	↑	+146.2%	+146.2%
2016.03	2015/10/30	Q2予	10,000	→	0.0%	0.0%	200	→	0.0%	0.0%	160	→	0.0%	0.0%	130	→	0.0%	0.0%
2016.03	2015/07/31	Q1予	10,000	→	0.0%	0.0%	200	→	0.0%	0.0%	160	→	0.0%	0.0%	130	→	0.0%	0.0%
2016.03	2015/04/30	当初予	10,000	-	-	-	200	-	-	-	160	-	-	-	130	-	-	-
2015.03	2015/04/30	実	10,038	↓	-3.5%	-3.5%	159	↓	-27.7%	-27.7%	124	↓	-22.5%	-22.5%	153	↑	+9.3%	+9.3%
2015.03	2015/01/30	Q3予	10,400	→	0.0%	0.0%	220	→	0.0%	0.0%	160	→	0.0%	0.0%	140	→	0.0%	0.0%
2015.03	2014/10/31	Q2予	10,400	→	0.0%	0.0%	220	→	0.0%	0.0%	160	→	0.0%	0.0%	140	→	0.0%	0.0%
2015.03	2014/07/25	Q1予	10,400	→	0.0%	0.0%	220	→	0.0%	0.0%	160	→	0.0%	0.0%	140	→	0.0%	0.0%
2015.03	2014/04/30	当初予	10,400	-	-	-	220	-	-	-	160	-	-	-	140	-	-	-
2014.03	2014/04/30	実	10,901	↑	+0.9%	+0.9%	342	↑	+6.9%	+6.9%	287	↑	+10.4%	+10.4%	309	↑	+6.6%	+6.6%
2014.03	2014/03/28	当初予	10,800	-	-	-	320	-	-	-	260	-	-	-	290	-	-	-

【7897】ホクシン 中質繊維版。大株主に兼松。 類似企業： 【業界1位】 ヤマハ 【売上同水準】 アルメディオ ドリームベット

【7897】ホクシン

中質繊維版。大株主に兼松。

類似企業：

【業界1位】ヤマハ

【売上同水準】アルメディオドリームベット